Name: Aldeyra Therapeutics, Inc. (ALDX) Balance Sheet
Creator: FinSpry

Aldeyra Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Aldeyra Therapeutics, Inc. (ALDX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	54.53	142.82	144.42	125.00	52.86	56.94	93.60
Short-Term Investments	46.62	0.00	29.88	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	101.15	142.82	174.30	125.00	52.86	56.94	93.60
Accounts Receivable	0.00	0.00	3.24	0.03	25.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.71	0.18	0.44	104.79	0.41	16.43	0.00
Total Current Assets	104.07	147.81	181.02	232.75	83.06	75.17	94.77
Non-Current Assets
Property, Plant & Equipment (Net)	0.27	0.52	0.27	0.38	0.29	0.20	0.24
Other Non-Current Assets	0.27	142.82	-0.08	-0.20	-0.35	16.43	0.00
Total Non-Current Assets	0.53	0.52	0.27	0.38	0.29	0.20	0.32
Total Assets	104.61	148.33	181.29	233.14	83.35	75.52	95.09
Current Liabilities
Accounts Payable	0.18	1.34	0.13	11.54	0.38	12.68	7.30
Short-Term Debt	0.03	15.15	0.91	0.00	3.66	0.00	0.00
Current Portion of Long-Term Debt	0.03	15.15	0.91	0.00	3.66	0.00	0.00
Accrued Liabilities	12.12	2.45	10.24	9.01	5.63	0.00	0.00
Deferred Revenue	6.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	12.12	3.09	3.82	1.51	2.50	0.00	0.00
Total Current Liabilities	18.60	22.26	15.36	11.77	12.41	12.91	8.47
Non-Current Liabilities
Long-Term Debt	15.00	0.27	14.92	15.63	11.43	14.53	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	15.00	6.27	14.92	15.63	11.43	14.53	0.00
Total Liabilities	33.60	28.53	30.28	27.40	23.84	27.44	8.47
Stockholders' Equity
Common Stock	0.06	0.06	0.06	0.06	0.04	0.00	0.00
Retained Earnings	-450.11	-394.26	-356.72	-294.69	-236.92	-199.36	-138.54
Accumulated Other Comprehensive Income	0.04	0.00	-0.10	0.00	0.00	0.01	-0.01
Additional Paid-in Capital	521.02	513.99	507.77	500.37	296.39	247.41	225.14
Shares Outstanding	59.65	59.20	58.56	58.08	0.00	0.00	0.00
Total Stockholders' Equity	71.00	119.80	151.01	205.74	59.51	48.08	86.62
Total Liabilities & Equity	104.61	148.33	181.29	233.14	83.35	75.52	95.09